qPCR arrays
ACT Genomics, UCSD Partner for Tumor Microenvironment Immunotherapy Study
The company is hoping its technology can help predict which melanoma patients will respond to checkpoint inhibition using immune-related gene expression signals.
The company is hoping its technology can help predict which melanoma patients will respond to checkpoint inhibition using immune-related gene expression signals.